Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer’s Disease

by palligoelme@gmail.com | Apr 11, 2025 | Clinical Trials

​ Conditions: Alzheimer’s Disease (AD) Interventions: Diagnostic Test: Multimodal Ophthalmic Imaging and plasma biomarker Sponsors: Peking University First Hospital Recruiting Conditions: Alzheimer’s Disease (AD) Interventions: Diagnostic Test: Multimodal...

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

by palligoelme@gmail.com | Apr 11, 2025 | Clinical Trials

​ Conditions: Age-Related Macular Degeneration Interventions: Other: Retinal Imaging Sponsors: University of Wisconsin, Madison Not yet recruiting Conditions: Age-Related Macular Degeneration Interventions: Other: Retinal Imaging Sponsors: University of Wisconsin,...

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

by palligoelme@gmail.com | Apr 11, 2025 | Clinical Trials

​ Conditions: Advanced NSCLC Interventions: Drug: JS207 injection Sponsors: Shanghai Junshi Bioscience Co., Ltd. Not yet recruiting Conditions: Advanced NSCLC Interventions: Drug: JS207 injection Sponsors: Shanghai Junshi Bioscience Co., Ltd. Not yet...

Predicting Nurse Staffing Requirements From Routinely Collected Data

by palligoelme@gmail.com | Apr 11, 2025 | Clinical Trials

​ Conditions: Nursing Workload Sponsors: University of Southampton; Imperial College London; Imperial College Healthcare NHS Trust; Portsmouth Hospitals NHS Trust; NHS England Not yet recruiting Conditions: Nursing Workload Sponsors: University of Southampton;...

MSCopilot Users’ Feedback in Real Life – Outcomes Regarding Integration in Patients’ pathWay and Users’ ExpeRience

by palligoelme@gmail.com | Apr 11, 2025 | Clinical Trials

​ Conditions: Multiple Sclerosis Interventions: Device: MSCopilot Flower mobile application Sponsors: Ad scientiam Not yet recruiting Conditions: Multiple Sclerosis Interventions: Device: MSCopilot Flower mobile application Sponsors: Ad scientiam Not yet...